title: [Aseptic meningitis following treatment with immunoglobulins: physiopathological and prognostic value of screening].
authors.forename: S
authors.initials: S
authors.lastname: Oddou
authors.forename: S
authors.initials: S
authors.lastname: Molinier
authors.forename: D
authors.initials: D
authors.lastname: Coso
authors.forename: J M
authors.initials: JM
authors.lastname: Boulet
authors.forename: J A
authors.initials: JA
authors.lastname: Gastaut
authors.forename: R
authors.initials: R
authors.lastname: Bouabdallah
mesh_terms: D000293:Adolescent; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000009:adverse effects* / Q000627:therapeutic use; D008582:Meningitis, Aseptic / Q000139:chemically induced* / Q000517:prevention & control; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000188:drug therapy*
chemical_list: D016756:Immunoglobulins, Intravenous
vernacular_title: Méningite aseptique consécutive à un traitement par immunoglobulines: intérêt physiopathologique et prognostique de son dépistage.